he global magnitude of sepsis coupled with the unacceptably high
attendant mortality continues to fuel universal efforts to improve
its early detection and the assessment of severity of disease in the
pursuit of improving clinical outcomes.[[1,2]] The quick Sequential
Organ Failure Assessment (qSOFA) score was introduced in
conjunction with the Sepsis-3 definition – the intention being that a
positive qSOFA score would serve as a screening tool for sepsis and
for predicting poor outcomes in such patients.[[3,4]] The qSOFA score is
based on three variables: a Glasgow Coma Score <15, a respiratory rate
≥22 breaths per minute, and a systolic blood pressure ≤100 mmHg.
The simultaneous presence of two of these variables indicates a
positive qSOFA. There is no directive on how to gauge change in
mentation at baseline for patients with altered mental status. The
appeal of qSOFA score is related to it being immediately calculated
without additional investigations and the ease of its derivation.qSOFA was initially validated for predicting poor outcomes
in sepsis outside of the intensive care unit (ICU).[[4]] As a sepsis
screening tool, it has not been demonstrated to be consistently
reliable in the emergency department (ED) or ICUs, even when
compared with the now out-of-vogue systemic inflammatory
response syndrome (SIRS) criteria.[[5-8]] The 2021 updated sepsis
guidelines caution against the sole reliance on qSOFA for the
early detection of sepsis.[[9]] In terms of predicting mortality in
patients with suspected or confirmed sepsis, most of the evidence
emanates from the ED, where the value of the qSOFA to predict
poor outcomes is variable or even inferior to other models such as
SIRS, the national early warning score (NEWS) and the modified
early warning score (MEWS).[[10-16]] Studies conducted in the ICU
setting are scarce but have also not been promising.[[17]] Clinicians
practising in resource-limited regions could argue that qSOFA may
fare differently in their patients taking into account the differences
in patient profile, pathophysiology and microbiology that occur
with economic disparities. In poorly resourced environments, the
ability to predict poor outcomes would be immensely valuable to
optimising the efficient use of scarce ICU resources.In this issue of the , Bishop et al.[[18]] retrospectively
evaluated the role of a positive qSOFA score in predicting mortality
in medical and surgical patients with suspected infection from the
database of a regional hospital’s critical care unit comprising of high
care (HC) and ICU patients. The predictive ability of qSOFA for all
patients in their database, including those without infections, has
been previously reported.[[18,19]] This cohort of 1 162 patients consists
predominantly of surgical patients (60%) who were mechanically
ventilated. This is a useful study, and the authors ought to be
congratulated for their efforts, considering the paucity of qSOFA
data in ICU settings, the need for data from poorly resourced regions
and the global lack of qSOFA data for surgical cohorts in particular.
Their observation of a positive qSOFA score being highly associated
with but poorly discriminant for in-ICU mortality among medical
and surgical patients highlights that while a positive qSOFA score
should raise alarm bells for medical and surgical patients upon
admission to a critical care unit, we still need to explore how we
can add on to the score or find alternative readily available practical
tools to identifypatients with a high risk for ICU mortality, with
greater and more acceptable levels of certainty. Addition of age, sex
and HIV status only marginally improved the discriminatory power
for medical and surgical patients.Interestingly, the recent ACCCOS study which evaluated
COVID-19 outcomes in 3 154 patients admitted to HC units or ICUs
in Africa, reported a very high mortality in patients with a qSOFA
score of 3.[[20]] Data from developing countries suggest that a positive
qSOFA score is associated with a higher risk of mortality in patients
with infections.[[21,22]] The discriminatory power of qSOFA is, however,
variable and sometimes inferior to other available scores.[[22]]The overall accuracy or discriminatory power of a predictive tool is
extremely important. In the context of making meaningful management
decisions with the use of a qSOFA score, the ED physician would prefer
a highly sensitive tool to avoid missing an infection, while an intensivist
would favour a tool with higher specificity to be able to exclude an
infection with certainty.It should be highlighted that using predictive scoring systems for
individual patient triage purposes is complex, as they are typically
designed to predict outcomes in a cohort of patients. Lead-time bias
is a reality and as our management practices evolve over time, models
need to be amended to retain or enhance their discriminatory power.
As such, no predictive tool will ever be singularly fully accurate to
predict mortality for an individual patient, and at best, it will serve as
an adjunctive tool to inform decision making.It would thus be prudent to consider the use of a combination of tools
or layering with add-on processes to improve efficiencies for resource
allocation purposes. In the context of ICU mortality, prediction of
sepsis for triage purposes, the role of qSOFA with NEWS, MEWS, or
universal vital assessment (UVA) as well as machine learning warrant
further exploration. Additionally, the role of multiple score assessments
(evaluating score change over time) would probably add more value
if used for triage purposes. Where available, the role of biochemical
markers such as lactate and inflammatory markers should also not be
disregarded.As the clinical outcomes for sepsis improve, the endpoint of
mortality for prediction tools may well need to be reconsidered to
ensure meaningful comparisons. Finally, despite the lack of robust
supportive evidence for qSOFA as a screening tool for infections,
it is still important that a positive qSOFA score be regarded as a
‘red flag alert’, that the possibility of sepsis ought to be considered,
and the patient be accordingly evaluated for an infection. A positive
qSOFA score in a patient with suspected or confirmed sepsis also
flags the patient in view of the observed associations with mortality.
Authors: Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Sung Yeon Hwang; Ik Joon Jo; Se Uk Lee; Tae Rim Lee; Hee Yoon; Won Chul Cha; Min Seob Sim; Tae Gun Shin Journal: Ann Emerg Med Date: 2017-06-29 Impact factor: 5.721
Authors: Matthew M Churpek; Ashley Snyder; Xuan Han; Sarah Sokol; Natasha Pettit; Michael D Howell; Dana P Edelson Journal: Am J Respir Crit Care Med Date: 2017-04-01 Impact factor: 21.405
Authors: Kristina E Rudd; Christopher W Seymour; Adam R Aluisio; Marc E Augustin; Danstan S Bagenda; Abi Beane; Jean Claude Byiringiro; Chung-Chou H Chang; L Nathalie Colas; Nicholas P J Day; A Pubudu De Silva; Arjen M Dondorp; Martin W Dünser; M Abul Faiz; Donald S Grant; Rashan Haniffa; Nguyen Van Hao; Jason N Kennedy; Adam C Levine; Direk Limmathurotsakul; Sanjib Mohanty; François Nosten; Alfred Papali; Andrew J Patterson; John S Schieffelin; Jeffrey G Shaffer; Duong Bich Thuy; C Louise Thwaites; Olivier Urayeneza; Nicholas J White; T Eoin West; Derek C Angus Journal: JAMA Date: 2018-06-05 Impact factor: 56.272
Authors: Velma Herwanto; Amith Shetty; Marek Nalos; Mandira Chakraborty; Anthony McLean; Guy D Eslick; Benjamin Tang Journal: Crit Care Explor Date: 2019-09-17
Authors: Bayode R Adegbite; Jean R Edoa; Wilfrid F Ndzebe Ndoumba; Lia B Dimessa Mbadinga; Ghyslain Mombo-Ngoma; Shevin T Jacob; Jamie Rylance; Thomas Hänscheid; Ayola A Adegnika; Martin P Grobusch Journal: EClinicalMedicine Date: 2021-10-30
Authors: Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi Journal: Lancet Date: 2020-01-18 Impact factor: 202.731